文献速递泌尿生殖腹部PETCTMR

基于18F-前列腺特异性膜抗原-1007 PET/CT与多参数MRI的多模态影像组学预测前列腺癌包膜外侵犯

Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction.
PubMed 文献 · Br J Radiol · 2024-01-01

纳入197例术前接受mpMRI和PET/CT的前列腺癌患者,构建mpMRI、PET/CT及多模态影像组学模型预测包膜外侵犯。训练队列AUC分别为0.85、0.73、0.83,测试队列为0.74、0.62、0.77;mpMRI模型优于PET/CT模型,多模态模型优于单一PET/CT模型(P < .05)。

要点

  • mpMRI影像组学模型预测包膜外侵犯优于PET/CT模型,临床获益更好。
  • 多模态影像组学模型(mpMRI+PET/CT)预测性能优于单一PET/CT模型(P < .05)。
  • 训练队列AUC:mpMRI 0.85、PET/CT 0.73、多模态0.83;测试队列分别为0.74、0.62、0.77。

核心结论

  • mpMRI与18F-PSMA-PET/CT联合可提高对前列腺癌患者包膜外侵犯的预测能力,多模态影像组学模型有望成为辅助泌尿外科医生和放射科医生术前决策的可靠工具。

研究设计与样本

  • 纳入197例前列腺癌患者,术前均行mpMRI和PET/CT检查;分割图像勾画感兴趣区并提取影像组学特征,基于最大相关最小冗余和逻辑回归分析构建PET/CT、mpMRI及多模态影像组学模型;采用受试者工作特征曲线下面积(AUC)和混淆矩阵衍生指标评估模型性能。

诊断标准与关键数值

  • 训练队列AUC:mpMRI模型0.85(95% CI 0.78-0.90)、PET/CT模型0.73(95% CI 0.64-0.80)、多模态模型0.83(95% CI 0.75-0.89);测试队列AUC:mpMRI模型0.74(95% CI 0.61-0.85)、PET/CT模型0.62(95% CI 0.48-0.74)、多模态模型0.77(95% CI 0.64-0.87);净重分类改善显示mpMRI影像组学模型预测包膜外侵犯优于PET/CT模型;多模态影像组学模型优于单一PET/CT影像组学模型(P < .05)。

临床应用与阅片要点

  • 作者认为多模态影像组学模型将成为辅助泌尿外科医生和放射科医生进行术前决策的可靠工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the performance of the multiparametric magnetic resonance imaging (mpMRI) radiomics and 18F-Prostate-specific membrane antigen (PSMA)-1007 PET/CT radiomics model in diagnosing extracapsular extension (EPE) in prostate cancer (PCa), and to evaluate the performance of a multimodal radiomics model combining mpMRI and PET/CT in predicting EPE.

METHODS: We included 197 patients with PCa who underwent preoperative mpMRI and PET/CT before surgery. mpMRI and PET/CT images were segmented to delineate the regions of interest and extract radiomics features. PET/CT, mpMRI, and multimodal radiomics models were constructed based on maximum correlation, minimum redundancy, and logistic regression analyses. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and indices derived from the confusion matrix.

RESULTS: AUC values for the mpMRI, PET/CT, and multimodal radiomics models were 0.85 (95% CI, 0.78-0.90), 0.73 (0.64-0.80), and 0.83 (0.75-0.89), respectively, in the training cohort and 0.74 (0.61-0.85), 0.62 (0.48-0.74), and 0.77 (0.64-0.87), respectively, in the testing cohort. The net reclassification improvement demonstrated that the mpMRI radiomics model outperformed the PET/CT one in predicting EPE, with better clinical benefits. The multimodal radiomics model performed better than the single PET/CT radiomics model (P < .05).

CONCLUSION: The mpMRI and 18F-PSMA-PET/CT combination enhanced the predictive power of EPE in patients with PCa. The multimodal radiomics model will become a reliable and robust tool to assist urologists and radiologists in making preoperative decisions.

ADVANCES IN KNOWLEDGE: This study presents the first application of multimodal radiomics based on PET/CT and MRI for predicting EPE.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Pan K, Yao F, Hong W, et al. Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction. Br J Radiol. 2024. PMID: 38308032. doi:10.1093/bjr/tqad038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。